2.
Points allocated to each prognostic factor to calculate an overall prognostic score for OS and PFS.
| 0 | 1 | 2 | 3 | 4 | 5 | |
| <LLN, below the lower limit of normal; >ULN, above the upper limit of normal; ECOG PS, Eastern Cooperative Oncology Group performance status; LDH, lactic dehydrogenase; LMR, lymphocyte to monocyte ratio; WBC, white blood cells | ||||||
| EGFR mutation | DEL19/L858R/
Other |
T790M | ||||
| Gender | Female | Male | ||||
| Smoking history | Never | Current or previous | ||||
| Time from diagnosis | > 12 months | < 12 months | ||||
| ECOG PS | 0 | 1+ | ||||
| Liver metastases | No | Yes | ||||
| Brain metastases | No | Yes | ||||
| Bone metastases | No | Yes | ||||
| Pleural effusion metastases | No | Yes | ||||
| LDH | Normal | > ULN | ||||
| Haemoglobin | Normal | < LLN | ||||
| WBC | Normal | > ULN | ||||
| LMR below 3 | No | Yes | ||||